CATX
Price
$2.96
Change
-$0.11 (-3.58%)
Updated
Dec 18, 04:59 PM (EDT)
99 days until earnings call
DHR
Price
$228.18
Change
-$5.35 (-2.29%)
Updated
Dec 18, 04:59 PM (EDT)
48 days until earnings call
Ad is loading...

CATX vs DHR

Header iconCATX vs DHR Comparison
Open Charts CATX vs DHRBanner chart's image
Perspective Therapeutics
Price$2.96
Change-$0.11 (-3.58%)
Volume$15.63K
CapitalizationN/A
Danaher
Price$228.18
Change-$5.35 (-2.29%)
Volume$32.27K
CapitalizationN/A
CATX vs DHR Comparison Chart
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. DHR commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and DHR is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CATX: $3.07 vs. DHR: $233.53)
Brand notoriety: CATX and DHR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CATX: 92% vs. DHR: 104%
Market capitalization -- CATX: $751.25M vs. DHR: $184.93B
CATX [@Medical Specialties] is valued at $751.25M. DHR’s [@Medical Specialties] market capitalization is $184.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whileDHR’s FA Score has 1 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • DHR’s FA Score: 1 green, 4 red.
According to our system of comparison, DHR is a better buy in the long-term than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 5 TA indicator(s) are bullish while DHR’s TA Score has 5 bullish TA indicator(s).

  • CATX’s TA Score: 5 bullish, 3 bearish.
  • DHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CATX is a better buy in the short-term than DHR.

Price Growth

CATX (@Medical Specialties) experienced а -15.89% price change this week, while DHR (@Medical Specialties) price change was -0.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.22%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +1.33%.

Reported Earning Dates

CATX is expected to report earnings on Mar 27, 2025.

DHR is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Medical Specialties (-4.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than CATX($751M). DHR YTD gains are higher at: 1.264 vs. CATX (-23.632). DHR has higher annual earnings (EBITDA): 7.5B vs. CATX (-39.08M). DHR has more cash in the bank: 5.86B vs. CATX (9.24M). CATX has less debt than DHR: CATX (2.55M) vs DHR (19.5B). DHR has higher revenues than CATX: DHR (23.9B) vs CATX (0).
CATXDHRCATX / DHR
Capitalization751M185B0%
EBITDA-39.08M7.5B-1%
Gain YTD-23.6321.264-1,870%
P/E RatioN/A43.86-
Revenue023.9B-
Total Cash9.24M5.86B0%
Total Debt2.55M19.5B0%
FUNDAMENTALS RATINGS
CATX vs DHR: Fundamental Ratings
CATX
DHR
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
10032
SMR RATING
1..100
9880
PRICE GROWTH RATING
1..100
6659
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
30n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CATX's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for DHR (70) in the Medical Specialties industry. This means that CATX’s stock grew somewhat faster than DHR’s over the last 12 months.

DHR's Profit vs Risk Rating (32) in the Medical Specialties industry is significantly better than the same rating for CATX (100) in the Biotechnology industry. This means that DHR’s stock grew significantly faster than CATX’s over the last 12 months.

DHR's SMR Rating (80) in the Medical Specialties industry is in the same range as CATX (98) in the Biotechnology industry. This means that DHR’s stock grew similarly to CATX’s over the last 12 months.

DHR's Price Growth Rating (59) in the Medical Specialties industry is in the same range as CATX (66) in the Biotechnology industry. This means that DHR’s stock grew similarly to CATX’s over the last 12 months.

DHR's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for CATX (100) in the Biotechnology industry. This means that DHR’s stock grew somewhat faster than CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXDHR
RSI
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 10 days ago
59%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Ad is loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-11.78%
STRR - CATX
91%
Closely correlated
-2.02%
RBOT - CATX
40%
Loosely correlated
-2.67%
BJDX - CATX
33%
Loosely correlated
-12.22%
DHR - CATX
24%
Poorly correlated
-0.28%
NVYTF - CATX
24%
Poorly correlated
N/A
More

DHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHR
1D Price
Change %
DHR100%
-0.28%
TMO - DHR
77%
Closely correlated
-0.27%
WAT - DHR
68%
Closely correlated
-0.08%
A - DHR
63%
Loosely correlated
-0.88%
RVTY - DHR
52%
Loosely correlated
-0.36%
BRKR - DHR
46%
Loosely correlated
+1.10%
More